>

White Papers

Oncology Competitive Landscape, April 2020: Searching for White Space

A comprehensive report that can serve as a starting point for any strategic indication prioritization exercise covering 21 major oncology tumors.

Services Area

Commercial Strategy

Therapeutic Area

Oncology

In Vivo Gene Therapy for Mainstream Diseases - Making Inroads Beyond the Rare and Orphan

First Principles gives its view on the rapid changes in the gene therapy field in 2018 and 2019, trying to give insight on the ability of gene therapy to get beyond niche indications.

Services Area

Commercial Strategy

Therapeutic Area

Gene Therapy & Orphan Disease

A Primer on Pharmaceutical Pricing, Costs and Reimbursement

Pharmaceutical pricing is perhaps most controversial and enigmatic issue facing pharma today. This extensive paper crosses many topics to review the economic mechanisms beyond price and where it may go tomorrow. This paper will also be presented in blog form given the extensive nature of the topic.

Services Area

Commercial Strategy

Therapeutic Area

N/A

Advanced Therapies in Oncology: CAR-T Background, Supply Chain Considerations, and Recent FDA Insights

In this paper written in 2017, First Principles surveys the CAR-T landscape to discuss clinical challenges in these therapies as compared to past innovations.

Services Area

Commercial Strategy

Therapeutic Area

Oncology

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net